Peptide selectivity discriminates NK cells from KIR2DL2‐ and KIR2DL3‐positive individuals
Open Access
- 31 October 2014
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 45 (2) , 492-500
Abstract
Natural killer cells are controlled by peptide selective inhibitory receptors for MHC class I, including the killer cell immunoglobulin‐like receptors (KIRs). Despite having similar ligands, KIR2DL2 and KIR2DL3 confer different levels of protection to infectious disease. To investigate how changes in peptide repertoire may differentially affect NK cell reactivity, NK cells from KIR2DL2 and KIR2DL3 homozygous donors were tested for activity against different combinations of strong inhibitory (VAPWNSFAL), weak inhibitory (VAPWNSRAL), and antagonist peptide (VAPWNSDAL). KIR2DL3‐positive NK cells were more sensitive to changes in the peptide content of MHC class I than KIR2DL2‐positive NK cells. These differences were observed for the weakly inhibitory peptide VAPWNSRAL in single peptide and double peptide experiments (p < 0.01 and p < 0.03, respectively). More significant differences were observed in experiments using all three peptides (p < 0.0001). Mathematical modeling of the experimental data demonstrated that VAPWNSRAL was dominant over VAPWNSFAL in distinguishing KIR2DL3‐ from KIR2DL2‐positive donors. Donors with different KIR genotypes have different responses to changes in the peptide bound by MHC class I. Differences in the response to the peptide content of MHC class I may be one mechanism underlying the protective effects of different KIR genes against infectious disease.Keywords
Funding Information
- Wellcome Trust (WT076991MA)
This publication has 32 references indexed in Scilit:
- Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptorsGenome Research, 2012
- DRiPs solidify: progress in understanding endogenous MHC class I antigen processingTrends in Immunology, 2011
- Natural Killer Cell Responses to HIV-1 Peptides are Associated With More Activating KIR Genes and HLA-C Genes of the C1 AllotypeJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Peptide antagonism as a mechanism for NK cell activationProceedings of the National Academy of Sciences, 2010
- Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus InfectionJournal of Virology, 2010
- The Yin and Yang of HLA and KIR in human diseaseSeminars in Immunology, 2008
- Negative signaling by inhibitory receptors: the NK cell paradigmImmunological Reviews, 2008
- Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcomeMolecular Immunology, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responsesJournal of Clinical Investigation, 2008